Source: Υπουργείο Υγείας (CY) Revision Year: 2019 Publisher: Medochemie Ltd, 1-10 Constantinoupoleos Street 3011, Cyprus
Vacontil 2 mg capsules.
| Pharmaceutical Form |
|---|
|
Capsule, hard. Dark green – Grey gelatine capsules size ‘4’. |
Each capsule contains loperamide hydrochloride 2 mg.
Excipient with known effect: lactose monohydrate.
For full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Loperamide |
By binding to opiate receptors in the gut wall, loperamide hydrochloride reduces propulsive peristalsis, increases intestinal transit time and enhances resorption of water and electrolytes. Loperamide increases the tone of the anal sphincter, which helps reduce faecal incontinence and urgency. |
| List of Excipients |
|---|
|
Capsule core: Lactose monohydrate Capsule shell: Gelatin |
Blister boxes with 10 or 20 capsules.
Blister boxes with 30 or 1000 capsules.
Not all pack sizes may be marketed.
Medochemie Ltd, 1-10 Constantinoupoleos Street 3011, Cyprus
8524
First authorisation date: 22.10.1982
Renewal date: 15.06.2011
| Drug | Countries | |
|---|---|---|
| VACONTIL | Cyprus, Hong Kong, Malta, Singapore |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
